ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

REGN Regeneron Pharmaceuticals Inc

1 045,69
19,14 (1,86%)
15 Juin 2024 - Fermé
Retardé de 15 minutes

Période:

Mode Dessin:

Volume 353 917
Prix Achat 1 036,87
Prix Vente 1 046,00
Actualités (1)
Maximum Haut 1 042,66

Bas
684,805

Sur 52 semaines

Haut
1 042,66

Minimum Bas 1 028,285
Nom Action Symbole Action Marché Type
Regeneron Pharmaceuticals Inc REGN NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
19,14 1,86% 1 045,69 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
1 024,30 1 028,285 1 042,66 1 036,52 1 026,55
Transactions Totales Volume échangé VWAP Volume Financier Volume en moyenne Sur 52 semaines
16 560 353 917 US$ 1 034,70 US$ 366 196 964 - 684,805 - 1 042,66
Dernière Transaction Type Quantités échangées Prix transaction Devise
01:46:16 1 US$ 1 044,78 USD

Flux d'options Regeneron Pharmaceuticals (REGN)

Flux global

Haussier

Prime nette

2M

Calls / Puts

800,00%

Ach. / Vent.

66,67%

OTM / ITM

50,00%

Sweeps Ratio

0,00%

Bilan Comptable

Capitalisation Boursière Actions en Circulation Float Chiffre d'affaires Bénéfice/Perte BPA Ratio Cours sur Bénéfices
113,77B 109,76M - 13,12B 3,95B 36,02 28,78
Short Interest Dividendes Par Action Rendement du Dividende Ex-Div Date Insider B/S Insider % Owned
- - - -

plus d’informations financières »

Actualités Action Regeneron Pharmaceuticals

Date Heure Source Titre
14/6/202422:26Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
13/6/202422:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
12/6/202423:04Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
12/6/202422:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
12/6/202422:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
11/6/202413:00GlobeNewswire Inc.Kevzara® (sarilumab) Approved by FDA for the Treatment of..
10/6/202422:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
07/6/202422:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
06/6/202422:12Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
05/6/202422:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
05/6/202422:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
05/6/202420:24Edgar (US Regulatory)Form 144 - Report of proposed sale of securities

Forum Action Regeneron Pharmaceuticals

Aucune Discussion TrouvéeAjouter une Discussion

Historiques Regeneron Pharmaceuticals Inc

Période Ouver. Haut Bas VWAP Moyenne Vol. Quot. Variation %
1 semaine999,001 042,66992,221 015,61343 59346,694,67%
1 mois969,271 042,66952,30992,20383 91376,427,88%
3 mois973,001 042,66875,225949,48427 11372,697,47%
6 mois873,811 042,66838,455936,78495 118171,8819,67%
1 an766,071 042,66684,805858,08514 634279,6236,50%
3 ans525,621 042,66516,75717,87634 241520,0798,94%
5 ans306,811 042,66271,37596,76761 045738,88240,83%

Dernières Valeurs Consultées

Delayed Upgrade Clock